The scientific journal Cardiovascular and Hematological Disorders - Drug Targets is included in the Scopus database.
Based on 2020, SJR is 0.33.
Publisher country is United Arab Emirates.
The main subject areas of published articles are Molecular Medicine, Medicine(all), Cardiology and Cardiovascular Medicine, Hematology, Pharmacology.
We offer making basic requirements to academic papers compliance test using "Paper quality checking" service.
Paper quality checking service is in demand among researchers who wish to make final improvements to their work before submitting it to the target journal.The experienced editors of ORES, who have published papers in cited journals, with the participation of foreign partners go through finished articles. They perform complex checks on many parameters, improve the structure and logic of content, and conduct spell checks, among others.
| Percentile | Scopus ASJC Code | Scopus Sub-Subject Area | Quartile |
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | 2720 | Hematology | 3 |
| 18 | 1313 | Molecular Medicine | 4 |
| 39 | 2705 | Cardiology and Cardiovascular Medicine | 3 |
| 31 | 3004 | Pharmacology | 3 |
| Web Site | Articles in 2018 | Articles in 2019 | Articles in 2020 |
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Link | 32 | 27 | 33 |
